NAII — Natural Alternatives International Share Price
- $35.16m
- $32.05m
- $154.02m
- 76
- 94
- 30
- 74
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.48 | ||
Price to Tang. Book | 0.48 | ||
Price to Free Cashflow | 6.22 | ||
Price to Sales | 0.33 | ||
EV to EBITDA | 20.38 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -2.03% | ||
Return on Equity | -3.87% | ||
Operating Margin | -2.36% |
Financial Summary
Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 138.29 | 118.88 | 178.52 | 170.97 | 154.01 | n/a | n/a | 3.06% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -21.29 | n/a | n/a | +3.11 | -75.34 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. The Company operates through two segments: Private-label contract manufacturing, and Royalty, licensing, and raw material. The Private-label contract manufacturing segment primarily provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. Royalty, licensing, and raw material segment associated with the sale and license of beta-alanine under the Company’s CarnoSyn and SR CarnoSyn trademarks. The Company provides private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal and other nutritional supplements as well as other health care products. It private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores.
Directors
- Mark Ledoux CHM (67)
- Kenneth Wolf PRE (60)
- Michael Fortin CFO (44)
- Alan Dunn IND (66)
- Laura Matherly IND (57)
- Guru Ramanathan IND (58)
- Last Annual
- June 30th, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- October 26th, 1989
- Public Since
- January 13th, 1997
- No. of Shareholders
- 181
- No. of Employees
- 317
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NASDAQ Global Market
- Shares in Issue
- 6,200,869
- Address
- 1535 Faraday Avenue, CARLSBAD, 92008
- Web
- https://www.nai-online.com/
- Phone
- +1 7607367700
- Auditors
- Haskell & White LLP
Upcoming Events for NAII
Q1 2025 Natural Alternatives International Inc Earnings Release
Natural Alternatives International Inc Annual Shareholders Meeting
Similar to NAII
111
NASDAQ Global Market
ADMA Biologics
NASDAQ Global Market
Alimera Sciences
NASDAQ Global Market
ANI Pharmaceuticals
NASDAQ Global Market
Aquestive Therapeutics
NASDAQ Global Market
FAQ
As of Today at 22:14 UTC, shares in Natural Alternatives International are trading at $6.46. This share price information is delayed by 15 minutes.
Shares in Natural Alternatives International last closed at $6.46 and the price had moved by -13.64% over the past 365 days. In terms of relative price strength the Natural Alternatives International share price has underperformed the S&P500 Index by -31.28% over the past year.
There is no consensus recommendation for this security.
Natural Alternatives International does not currently pay a dividend.
Natural Alternatives International does not currently pay a dividend.
Natural Alternatives International does not currently pay a dividend.
To buy shares in Natural Alternatives International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $6.46, shares in Natural Alternatives International had a market capitalisation of $40.06m.
Here are the trading details for Natural Alternatives International:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: NAII
Based on an overall assessment of its quality, value and momentum Natural Alternatives International is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Natural Alternatives International. Over the past six months, its share price has underperformed the S&P500 Index by -14.22%.
As of the last closing price of $6.46, shares in Natural Alternatives International were trading +2.49% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Natural Alternatives International PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $6.46.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Natural Alternatives International's management team is headed by:
- Mark Ledoux - CHM
- Kenneth Wolf - PRE
- Michael Fortin - CFO
- Alan Dunn - IND
- Laura Matherly - IND
- Guru Ramanathan - IND